Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Radiation oncologist says radiation quality assurance practices need to be standardized

In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.

3 Nov 2010

Deloitte releases new report on innovative strategies for oncology drug development

Deloitte released a new report, "Innovative Strategies for Oncology Drug Development," highlighting specific drug development approaches that have enabled biotech companies to produce a substantial number of first-in-class compounds and more than $1 billion in oncology drugs while transforming the medical outlook for many cancer patients.

3 Nov 2010

Incyte announces achievement of $50 million in INCB18424 clinical trial

Incyte Corporation announced today the achievement of $50 million in milestones as part of the Incyte-Novartis collaboration and license agreement for INCB18424.

3 Nov 2010

Integra launches XKnife 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software

Integra LifeSciences Holdings Corporation announced today the launch of its XKnife® 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software. The XKnife® 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software is part of Integra's XKnife® System and is indicated for Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT).

3 Nov 2010

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

AstraZeneca announced today that results from TITAN, a 12-week study of SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol in African American patients with moderate to severe persistent asthma, showed significant improvement in lung function for patients taking SYMBICORT compared with those using budesonide alone.

3 Nov 2010

LVI in breast tissue predicts recurrence of breast cancer in regional lymph nodes

Breast cancer, one of the most prevalent cancers in women, afflicts an additional 200,000 women each year and causes about 40,000 deaths annually. The disease often extends to neighboring lymph nodes, in part, through lymphovascular invasion (LVI)-a process in which cancer cells invade blood vessels or the lymphatic system-and can often translate into a poor prognosis for patients.

3 Nov 2010

GenVec receives $244,479 grant under QTDP program

GenVec, Inc. announced today that it was awarded a cash grant of approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.

3 Nov 2010

New technique could help scientists to predict how living prostate tissues respond to therapy

Scientists at the Johns Hopkins Kimmel Cancer Center, University of Helsinki and Stanford University have developed a technique to keep normal and cancerous prostate tissue removed during surgery alive and functioning normally in the laboratory for up to a week.

3 Nov 2010

Study finds risk of toxicity in Phase I radiation oncology clinical trials

Risks to patients enrolled in Phase I radiation oncology clinical trials are higher than previously appreciated, according to a study conducted by researchers from the Kimmel Cancer Center at Jefferson. The findings will be presented at the American Society of Radiation Oncology (ASTRO) annual meeting in San Diego.

3 Nov 2010

Celsion receives $244,000 grant under QTDP program

Celsion Corporation today announced that the company has been awarded a $244,000 grant under the Qualifying Therapeutic Discovery Project (QTDP) program under The Patient Protection and Affordable Care Act of 2010 (PPACA).

3 Nov 2010

Image Guided IMRT preserves sexual function in men after prostatectomy

Men battling prostate cancer who receive Image Guided Intensity Modulated Radiation Therapy after undergoing prostatectomy have an excellent chance of retaining sexual function, according to a study by Allegheny General Hospital (AGH) cancer specialists presented this week at the annual meeting of the American Society for Therapeutic Radiation and Oncology in San Diego.

3 Nov 2010

Neoprobe receives $244,479 grant under QTDP program

Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project program established under Section 48D of the Internal Revenue Code.

3 Nov 2010

CTI granted additional 180 days to regain compliance with NASDAQ minimum bid price rule

Cell Therapeutics, Inc. today announced that The NASDAQ Stock Market has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.

3 Nov 2010

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

GenMark Diagnostics, Inc. a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States.

3 Nov 2010

CytRx receives nontaxable grant under Qualifying Therapeutic Discovery Project Program

CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.

3 Nov 2010

Jelly fish glow may help detect early stage cancer

Researcher Professor Norman Maitland of the Yorkshire Cancer Research Laboratory at York University, feels that this technology could be at least ten times better than CT scanners at detecting tumors. He explained, “Cancers deep within the body are difficult to spot at an early stage and early diagnosis is critical for the successful treatment of any form of cancer.

2 Nov 2010

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has entered into a Cooperative Research and Development Agreement ("CRADA") with The Walter Reed Army Institute of Research.

2 Nov 2010

Pain Therapeutics awarded $2,000,000 U.S. government research grant

Pain Therapeutics, Inc. announced today that it has been awarded over $2,000,000 in research grants by the U.S. government. These grants are planned to support the Company's on-going biomedical research for nervous system disorders and oncology. Pain Therapeutics expects to receive funding from these research grants now through the end of 2011.

2 Nov 2010

Celldex third quarter net loss increases to $9.1 million

Celldex Therapeutics, Inc. today reported financial results for the third quarter ended September 30, 2010. Celldex reported a net loss of $9.1 million, or $0.28 per share, for the third quarter of 2010 compared to a net loss of $7.2 million, or $0.45 per share, for the third quarter of 2009. For the nine months ended September 30, 2010, Celldex reported a net loss of $25.2 million, or $0.79 per share, compared to a net loss of $23.6 million, or $1.49 per share, for the nine months ended September 30, 2009.

2 Nov 2010

IRS awards RXi Pharmaceuticals four Therapeutic Discovery Project grants

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded four Therapeutic Discovery Project (TDP) grants, totaling $977,917, by the United States Internal Revenue Service (IRS) as part of the Patient Protection and Affordable Care Act of 2010.

2 Nov 2010

Oncology News and Research

Further Reading

Radiation oncologist says radiation quality assurance practices need to be standardized

Deloitte releases new report on innovative strategies for oncology drug development

Incyte announces achievement of $50 million in INCB18424 clinical trial

Integra launches XKnife 5 Stereotactic Radiosurgery and Radiotherapy Treatment Planning Software

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

LVI in breast tissue predicts recurrence of breast cancer in regional lymph nodes

GenVec receives $244,479 grant under QTDP program

New technique could help scientists to predict how living prostate tissues respond to therapy

Study finds risk of toxicity in Phase I radiation oncology clinical trials

Celsion receives $244,000 grant under QTDP program

Image Guided IMRT preserves sexual function in men after prostatectomy

Neoprobe receives $244,479 grant under QTDP program

CTI granted additional 180 days to regain compliance with NASDAQ minimum bid price rule

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

CytRx receives nontaxable grant under Qualifying Therapeutic Discovery Project Program

Jelly fish glow may help detect early stage cancer

Advanced Life Sciences enters CRADA for Restanza with Walter Reed Army Institute of Research

Pain Therapeutics awarded $2,000,000 U.S. government research grant

Celldex third quarter net loss increases to $9.1 million

IRS awards RXi Pharmaceuticals four Therapeutic Discovery Project grants

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News